The Effect of Hologram Application on Pain, Anxiety, and Fear Levels in Children During Burn Dres… (NCT06992895) | Clinical Trial Compass
RecruitingNot Applicable
The Effect of Hologram Application on Pain, Anxiety, and Fear Levels in Children During Burn Dressing
Turkey (Türkiye)70 participantsStarted 2025-10-15
Plain-language summary
The process of dressing burn injuries has been shown to cause both physical and psychological difficulties. In children, this process is particularly associated with intense pain and anxiety. Consequently, in addition to pharmacological interventions, non-pharmacological methods such as distraction are employed. In recent years, the utilization of holograms as a method of alleviating pain has emerged as a novel approach. The employment of these visual illusions has been demonstrated to effectively distract children, thereby providing a means of reducing discomfort. The objective of this thesis is to evaluate the effects of hologram application on pain, anxiety, fear, and vital signs during burn dressing in children.
Who can participate
Age range
3 Years – 12 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* The subject has indicated their willingness to participate in the study. Physical and mental health.
* The age range of the subjects included in this study was from 3 to 12 years of age.
* The subject had never previously engaged in the practice of dressing a burn.
* The presence of only second degree burns
* Burn percentage is under 10%
Exclusion Criteria:
* The subject is unwilling or unable to provide informed consent or assent (if applicable).
* The subject has a history of significant physical or mental health disorders that may interfere with participation in the study.
* The subject is younger than 3 years old or older than 12 years old.
* The subject has previously engaged in the practice of burn dressing or similar procedures.
* The presence of burns other than second-degree burns (e.g., first-degree or third-degree burns).
* The percentage of burn area is greater than 10%.
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.